Novartis Ag (NVS) Short-term Investments (2009 - 2026)

Novartis Ag has disclosed Short-term Investments across 18 years of filings, most recently posting $74.0 million for Q2 2026.

• In Q2 2026, Short-term Investments fell 78.49% year-over-year to $74.0 million; the TTM figure through Jun 2026 stood at $74.0 million (down 78.49% YoY), while the FY2025 annual figure was $155.0 million, down 92.24% from the prior year.
• Short-term Investments came in at $74.0 million for Q2 2026 at Novartis Ag, down from $100.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $16.1 billion in Q2 2022 to a low of $46.0 million in Q1 2023.
• Average Short-term Investments over 5 years is $2.7 billion, with a median of $317.0 million recorded in 2023.
• Year-over-year, Short-term Investments jumped 6650.21% in 2022 and sank 99.07% in 2023.
• Over 5 years, Short-term Investments stood at $11.4 billion in 2022, then plunged by 90.93% to $1.0 billion in 2023, then surged by 93.04% to $2.0 billion in 2024, then sank by 92.24% to $155.0 million in 2025, then tumbled by 52.26% to $74.0 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $74.0 million in Q2 2026, $100.0 million in Q1 2026, and $155.0 million in Q4 2025.